- Trials with a EudraCT protocol (137)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (70)
137 result(s) found for: Environment.
Displaying page 1 of 7.
| EudraCT Number: 2018-000564-28 | Sponsor Protocol Number: IIBSP-QTL-2017-96 | Start Date*: 2018-05-23 |
| Sponsor Name:Institut de Recerca H. de la Santa Creu i Sant Pau - IIB Sant Pau | ||
| Full Title: Genetic characterization of drug-induced Long QT Syndrome | ||
| Medical condition: Drug-induced Long QT Syndrome | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-001357-31 | Sponsor Protocol Number: IIV-478 | Start Date*: 2021-05-03 |
| Sponsor Name:National Institute of Health and the Environment | ||
| Full Title: Immune Responses Induced by Vaccination Against COVID-19 in Dutch healthy subjects | ||
| Medical condition: Immune Responses Induced by Vaccination Against COVID-19 in Dutch healthy subjects | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-005355-32 | Sponsor Protocol Number: IIV-275 | Start Date*: 2014-03-06 |
| Sponsor Name:National Institute for Public Health and the Environment (RIVM, the Netherlands) | ||
| Full Title: Memory response against Bordetella pertussis in adults: immunological effects of an acellular pertussis booster vaccination | ||
| Medical condition: The vaccine administered in this study is used to prevent pertussis caused by the bacterium Bordetella pertussis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003156-31 | Sponsor Protocol Number: 38RC14.245 | Start Date*: 2014-09-03 |
| Sponsor Name:CHU GRENOBLE | ||
| Full Title: | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-011520-53 | Sponsor Protocol Number: ML 22508 | Start Date*: 2009-05-04 |
| Sponsor Name:Roche Slovensko s.r.o. | ||
| Full Title: Evaluation of Adherence and Persistence to Tocilizumab in combination with Methotrexate or Tocilizumab Monotherapy in patients with moderate to severe active rheumatoid arthritis in local environment | ||
| Medical condition: moderate to severe active rheumatoid arthritis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-003451-34 | Sponsor Protocol Number: intrusion | Start Date*: 2023-05-03 |
| Sponsor Name:Erasmus Medical Center | ||
| Full Title: INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 | ||
| Medical condition: metastatic non-squamous non-small cell lung cancer metastatic estrogen positive breast cancer metastatic gastric cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002363-22 | Sponsor Protocol Number: IIV-482 | Start Date*: 2021-05-27 |
| Sponsor Name:National Institute for Public Health and the Environment | ||
| Full Title: Vaccination of older persons against Sars-Cov-2 and cellular immunogenicity for long term protection (participating in the Doetinchem Cohort Study) | ||
| Medical condition: SARS-CoV-19, frailty | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003620-16 | Sponsor Protocol Number: IIV-465 | Start Date*: 2021-05-27 |
| Sponsor Name:National Institute of Health and the Environment | ||
| Full Title: Vaccine immunogenicity in Dutch frail versus non-frail older individuals (participating in the Doetinchem Cohort study) | ||
| Medical condition: Older adults 73-79 years of age, birth cohorts year 1941-1947, still participating in round 6 of the Doetinchem Cohort Study. | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-001864-50 | Sponsor Protocol Number: IIV-268 | Start Date*: 2013-07-22 |
| Sponsor Name:National Institute for Public Health and the Environment (RIVM, the Netherlands) | ||
| Full Title: Long-term memory immunity against Bordetella pertussis in children 9 years of age who have been vaccinated with acellular pertussis vaccines: effect of an extra preadolescent acellular booster vacc... | ||
| Medical condition: The vaccine administered in this study is used to prevent pertussis caused by the bacterium Bordetella pertussis | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-000967-42 | Sponsor Protocol Number: IIV-276 | Start Date*: 2014-05-20 |
| Sponsor Name:National Institute for Public Health and the Environment (RIVM) | ||
| Full Title: Strengthening memory immunity in the aged population by vaccinating re-elderly | ||
| Medical condition: The vaccine administered in this study is used to prevent meningococcal disease caused by the bacteria Neisseria meningitidis group A,C,W,Y (Nimenrix) and Herpes Zoster disease caused by the Vari... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001665-16 | Sponsor Protocol Number: 1312 | Start Date*: 2013-08-01 |
| Sponsor Name:University Hospital Grenoble | ||
| Full Title: Intranasal Sufentanyl analgesia Versus Morphine IV in Emergency room. | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-000923-33 | Sponsor Protocol Number: HepB/APAP/2011 | Start Date*: 2011-07-14 | ||||||||||||||||
| Sponsor Name:Rijksinstituut voor Volksgezondheid en Milieu (RIVM) | ||||||||||||||||||
| Full Title: Effects of paracetamol use on the immune response after hepatitis B vaccination | ||||||||||||||||||
| Medical condition: No medical conditions will be studied. The association between timing of the use of paracetamol during hepatitis B vaccination and the development of an antibody response will be studied in student... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-000982-19 | Sponsor Protocol Number: IOBA-ImmunEyez_011-2018 | Start Date*: 2019-12-11 |
| Sponsor Name:Instituto de Oftalmobiología Aplicada (IOBA) | ||
| Full Title: A Phase IV Open-Label Clinical Trial to Evaluate the Efficacy of Ikervis® on Clinical Parameters and Molecular/Cellular Biomarkers in Dry Eye Patients with Severe Keratitis who have not improved de... | ||
| Medical condition: Dry eye disease with severe keratitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004889-28 | Sponsor Protocol Number: FFR113342 | Start Date*: 2016-12-21 |
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent... | ||
| Medical condition: Rhinitis, Allergic, Perennial | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2005-001880-68 | Sponsor Protocol Number: 1001-PR-PRI-133 | Start Date*: 2005-09-23 |
| Sponsor Name:LETI Pharma GmbH | ||
| Full Title: Standardization of Latex allergenic extract. Determination of biological activity in HEP units | ||
| Medical condition: The objective of the study is to know the biologic activity of the Latex reference extract (IHRP) in HEP units. The HEP value will be the reference of every other diagnostic or treatment preparations. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000098-65 | Sponsor Protocol Number: 09012313 | Start Date*: 2013-09-13 |
| Sponsor Name:University of Tromsø | ||
| Full Title: Treatment of Axial Spondyloarthritis with reduced doses of NSAIDs: Application of pharmacotherapeutic conditioning in clinical practice. | ||
| Medical condition: Axial Spondyloarthritis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-006142-39 | Sponsor Protocol Number: ATB21 | Start Date*: 2021-08-13 |
| Sponsor Name:Facultad de Odontología. Universidad Complutense de Madrid | ||
| Full Title: INFLUENCE OF THE ANTIBIOTIC GUIDELINE ON IMPLANT SURVIVAL | ||
| Medical condition: Patients undergoing implant placement | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-001972-55 | Sponsor Protocol Number: 20963.091.08 | Start Date*: 2009-09-30 |
| Sponsor Name:UMC St Radboud | ||
| Full Title: Efficacy of hyperbaric oxygen therapy in the treatment of late radiation damage, osteoradionecrosis, of the lower jaw. | ||
| Medical condition: Osteoradionecrosis of the jaw due to previous radiotherapy treatment in the head and neck region | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-003686-36 | Sponsor Protocol Number: AR13001 | Start Date*: 2021-07-19 |
| Sponsor Name:Finnish Defence Forces | ||
| Full Title: Immune response to SARS-CoV-2 vaccines and its clinical significance in the Finnish Defence Forces | ||
| Medical condition: Immune response induced by SARS-CoV-2 vaccination. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001823-38 | Sponsor Protocol Number: IMS-267 | Start Date*: 2013-08-05 |
| Sponsor Name:National Institute of Public Health and Environment (RIVM, the Netherlands) | ||
| Full Title: Second meningococcal vaccination in Dutch children: Study to compare the tetravalent MenACWY-TT conjugate vaccine with the monovalent MenC-TT conjugate vaccine. | ||
| Medical condition: The monovalent MenC-TT vaccin administered in this study is used to prevent invasive disease caused by Meningococcal group C. The tetravelent MenACWY-TT vaccin administered in this study is used to... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
